Anethole trithione

From Wikipedia, the free encyclopedia
(Redirected from Anetholtrithione)
Jump to navigation Jump to search

Template:Short description Template:Cs1 config Template:Drugbox Anethole trithione, anetholtrithione, or anetholtrithion (JAN) is a drug used in the treatment of dry mouth. It is listed in the U.S. National Cancer Institute's Dictionary of Cancer Terms as being studied in the treatment of cancer.[1] Anethole trithione is an organosulfur compound, specifically, a dithiole-thione derivative.[2]

Brand names

  • Felviten
  • Halpen
  • Hepasulfol - Franco-Indian Pharmaceuticals
  • Heporal
  • Mucinol - Sanofi-Aventis
  • Sialor - Paladin Laboratories; Pharmascience; Solvay; Zuoz Pharma
  • Sonicur - Solvay
  • Sulfarlem - Solvay; Aguettant; Edward Keller; Sanofi-Aventis
  • Sulfarlem S - EG Labo
  • Tiopropen
  • Tiotrifar

See also

References

  1. ↑ Anetholtrithione entry in the public domain NCI Dictionary of Cancer Terms. Retrieved September 13, 2008.
  2. ↑ Script error: No such module "citation/CS1".

Script error: No such module "Navbox".

Template:Gastrointestinal-drug-stub

Retrieved from "http://debianws.lexgopc.com/wiki143/index.php?title=Anethole_trithione&oldid=5484311"